Effect of monoterpenes on the formation and activation of osteoclasts in vitro

被引:27
作者
Dolder, S [1 ]
Hofstetter, W [1 ]
Wetterwald, A [1 ]
Mühlbauer, RC [1 ]
Felix, R [1 ]
机构
[1] Univ Bern, Dept Clin Res, Bone Biol Grp, CH-3010 Bern, Switzerland
关键词
nutrition; monoterpenes; osteoclast; osteoblast;
D O I
10.1359/JBMR.060111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoterpenes, present in aromatic plants, are known to inhibit bone resorption in vivo. In this in vitro study, they inhibited the activation of osteoclasts only at high concentrations but inhibited the formation at much lower concentrations. Therefore, monoterpenes may act in vivo directly on osteoclastogenesis. Introduction: Monoterpenes are the major components of essential oils, which are formed in many plants. Typically, they are found in herbs and certain fruits. When fed to rats, they inhibit bone resorption by an unknown mechanism. In this study, their effect on the activity and formation of osteoclasts in vitro was studied. Materials and Methods: The effect of monoterpenes oil the development of osteoclasts was studied in co-cultures of bone marrow cells and osteoblasts and in cultures of spleen cells grown with colony stimulating factor (CSF)-1 and RANKL. In Cultures of primary osteoblasts, alkaline phosphatase activity and levels of mRNA encoding RANKL and osteoprotegerin (OPG) mRNA (RT-PCR), and in osteoblast and spleen cell cultures, lactate dehydrogenase activity, a measure of toxicity, were determined. The activity of isolated rat osteoclasts was determined by counting the osteoclasts with actin rings using histofluorometry. Results: The monoterpenes inhibited the formation of osteoclasts more strongly in co-cultures (>= 1 mu M) than in cultures of spleen cells (>= 10 mu M). They had a minor effect oil osteoblasts. Toxic effects were not observed. The inhibition of the formation of osteoclasts was not reversed by the addition of farnesol and geranylgeraniol, excluding an effect of the monoterpenes through the mevalonate pathway. A high concentration of 1 mM was required to inhibit the activation of osteoclasts. This effect, shown for menthol and borneol, was reversible. Conclusions: The results suggest that the monoterpenes inhibit bone resorption in vivo through a direct effect on the formation of osteoclasts acting mainly oil the hemopoietic cells.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 24 条
  • [1] Expression and regulation of RAB3 proteins in osteoclasts and their precursors
    Abu-Amer, Y
    Teitelbaum, SL
    Chappel, JC
    Schlesinger, P
    Ross, FP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) : 1855 - 1860
  • [2] Rho-A is critical for osteoclast podosome organization, motility, and bone resorption
    Chellaiah, MA
    Soga, N
    Swanson, S
    McAllister, S
    Alvarez, U
    Wang, DM
    Dowdy, SF
    Hruska, KA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) : 11993 - 12002
  • [3] Chow HHS, 2002, CANCER EPIDEM BIOMAR, V11, P1472
  • [4] Prevention and therapy of cancer by dietary monoterpenes
    Crowell, PL
    [J]. JOURNAL OF NUTRITION, 1999, 129 (03) : 775S - 778S
  • [5] CROWELL PL, 1991, J BIOL CHEM, V266, P17679
  • [6] STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG MONOTERPENE, INHIBITORS OF PROTEIN ISOPRENYLATION AND CELL-PROLIFERATION
    CROWELL, PL
    REN, ZB
    LIN, SZ
    VEDEJS, E
    GOULD, MN
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (08) : 1405 - 1415
  • [7] ELSON CE, 1995, J NUTR, V125, pS1666
  • [8] Gas chromatographic mass spectrometric identification of metabolites from alpha-pinene in human urine after occupational exposure to sawing fumes
    Eriksson, K
    Levin, JO
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (01): : 85 - 98
  • [9] Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
    Fisher, JE
    Rogers, MJ
    Halasy, JM
    Luckman, SP
    Hughes, DE
    Masarachia, PJ
    Wesolowski, G
    Russell, RGG
    Rodan, GA
    Reszka, AA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 133 - 138
  • [10] Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis
    Hosfield, DJ
    Zhang, YM
    Dougan, DR
    Broun, A
    Tari, LW
    Swanson, RV
    Finn, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) : 8526 - 8529